Skip to main content
. 2016 Apr;111(4):252–257. doi: 10.1590/0074-02760150390

TABLE III. Different outcomes according to the medication used.

ETV [n/n (%)] TDF [n/n (%)] p
HBV-DNA loss 146/165 (88.5) 240/288 (83.3) 0.376
HBeAg loss 19/24 (79) 18/25 (72) 0.508
Anti-HBe seroconvertion 3/19 (15.8) 1/18 (5.56) 0.604
ALT normalisation 36/72 (50) 68/128 (53.1) 0.671

ALT: alanine aminotransferase; anti-HBe: antibody to the e antigen; ETV: entecavir; HBeAg: hepatitis B e antigen; HBV: hepatitis B virus; TDF: tenofovir.